shortagewatch

Home / Companies / Novartis

Company family · HQ CH

Novartis: medicine shortages

NOVN · SIX Swiss

As of 2 Nov 2026, 70 Novartis products have a reported shortage across 11 countries, covering 32 medicines.

Products short70rank #28 of 464
Medicines32active ingredients
Countries11/16
New in 90 days31+21 vs market pace
Typical duration39 daysmedian so far
Manufacturing62%demand-driven 24%

Where

Canada27Italy9Spain11Ireland1Austria5Belgium5Switzerland1Czechia2Norway2Sweden4Japan3

Which therapeutic classes

Sensory organs18Cancer and immune system14Nervous system11Musculoskeletal system8Various7Cardiovascular system5Systemic hormones3Respiratory system2Dermatologicals2

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
NovartisNovartis: Manufacturing problem 28 (41%)41%Novartis: Increased demand 11 (16%)16%Novartis: Active ingredient shortage 3 (4%)4%Novartis: Distribution or logistics 1 (1%)Novartis: Not stated 25 (37%)37%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

Open shortages over time

2930303131 Oct2026-10-31: 301 Nov2026-11-01: 302 Nov2026-11-02: 30

Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.

When its current shortages began

05101520Dec: 0Jan ’25: 0Feb: 0FebMar: 0Apr: 0May: 1MayJun: 0Jul: 2Aug: 0AugSep: 0Oct: 0Nov: 0NovDec: 1Jan ’26: 1Feb: 0FebMar: 1Apr: 0May: 1MayJun: 0Jul: 4Aug: 3AugSep: 9Oct: 19Nov: 0Nov

Long-run trend in Canada

Canada dashboard
0122537502017: 2320172018: 4020182019: 3720192020: 3820202021: 420212022: 2020222023: 1020232024: 2120242025: 1520252026: 2120262027: 42027

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Novartis70

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Novartis: 70 / 32Novartis

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Deferasirox628 Jul 2026Manufacturing problem8/16
Diclofenac629 Jan 2026Not stated10/16
Dexamethasone and Antiinfectives516 Mar 2026Manufacturing problem5/16
Carbamazepine416 Oct 2023Manufacturing problem5/16
Erenumab420 Aug 2026Not stated3/16
Ciclosporin310 Sep 2026Not stated6/16
Everolimus326 Oct 2026Manufacturing problem1/16
Octreotide317 Jun 2024Manufacturing problem6/16
Oxcarbazepine323 Jul 2025Manufacturing problem4/16
Tobramycin36 Aug 2026Manufacturing problem4/16
Basiliximab21 Apr 2024Manufacturing problem2/16
Dexamethasone and Antiinfectives220 Nov 2026Increased demand2/16
Lapatinib227 Aug 2026Manufacturing problem2/16
Nepafenac220 Jul 2026Active ingredient shortage1/16
Secukinumab24 Aug 2023Increased demand2/16
Travoprost228 Sep 2026Not stated7/16
Valsartan and Diuretics227 Sep 2026Not stated7/16
Valsartan and Sacubitril220 Oct 2026Increased demand2/16
Alpelisib1not givenNot stated1/16
Baclofen131 Oct 2026Not stated3/16
Brinzolamide123 Oct 2026Manufacturing problem3/16
Gallium (68Ga) Gozetotide126 Oct 2026Not stated1/16
Indacaterol and Glycopyrronium Bromide128 Jul 2026Quality problem or recall1/16
Lapatinib115 Sep 2026Quality problem or recall1/16
Moxifloxacin15 Jan 2027Increased demand1/16
Omalizumab1not givenNot stated4/16
Ranibizumab1not givenNot stated2/16
Terbinafine1not givenNot stated5/16
Terbinafine126 Oct 2026Not stated3/16
Triamcinolone115 Jan 2027Active ingredient shortage2/16
Valsartan124 Sep 2026Increased demand7/16
Zoledronic Acid127 May 2025Manufacturing problem7/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.